Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Sanofi/Regeneron’s Dupixent shows more promise in nasal polyps
Pharmaforum
Tue, 02/26/19 - 11:48 pm
Tags:
Sanofi, Regeneron, Dupixent, clinical trials, nasal polyps
The fighter, the saint, and the odd man out: the executives who will defend pharma before Congress
Stat
Thu, 02/21/19 - 12:41 pm
Tags:
drug pricing, US Congress, Donald Trump, Richard Gonzalez, AbbVie, Ken Frazier, Merck, JNJ, Jennifer Taubert, Olivier Brandicourt, Sanofi, Pascal Soriot, AstraZeneca, Giovanni Caforio, Bristol-Myers Squibb, Albert Bourla, Pfizer
Sanofi handed payers nearly $12B in drug rebates last year
Biopharma Dive
Thu, 02/21/19 - 12:38 pm
Tags:
Sanofi, rebates, drug rebates, insurers, PBMs
It's not a Brexit problem, Sanofi says of epilepsy drug shortages
Fierce Pharma
Thu, 02/21/19 - 10:02 am
Tags:
Sanofi, drug shortages, Brexit, UK, epilepsy, Epilim, Depakote
With Obesity on the Continued Rise in the U.S., More Anti-Obesity Drugs Are Heading for the Market
BioSpace
Wed, 02/13/19 - 10:06 am
Tags:
obesity, Sanofi, Novo Nordisk, AstraZeneca
As digital medicine explodes in the zeitgeist of healthcare, Sanofi follows peers in appointing chief digital officer
Endpoints
Tue, 02/12/19 - 09:47 am
Tags:
digital pharma, digital medicine, chief technology officers, Sanofi
Regeneron, Sanofi cut PCSK9 list price, matching earlier move by rival Amgen
Biopharma Dive
Mon, 02/11/19 - 12:23 pm
Tags:
Regeneron, Sanofi, Amgen, Praluent, Repatha, drug pricing, PCSK9 inhibitors
Pharma companies clear the R&D decks in Q4
Pharmaforum
Mon, 02/11/19 - 12:20 pm
Tags:
R&D, GSK, Sanofi, Eli Lilly, Roche, Gilead Sciences
Sanofi’s latest R&D remodeling spotlights what’s hot (bispecifics) and what’s not (CTLA-4) in oncology today
Endpoints
Fri, 02/8/19 - 09:30 am
Tags:
Sanofi, oncology
Sanofi Cuts a Whopping 38 R&D Programs to Refocus on Cancer, Immunology, and Rare Diseases
BioSpace
Thu, 02/7/19 - 11:05 am
Tags:
Sanofi, Rare Diseases, immunology, cancer, R&D
Sanofi (SNY) Q4 Earnings Top, Genzyme Unit Drives Sales Growth
Yahoo/Zacks.com
Thu, 02/7/19 - 10:49 am
Tags:
Sanofi, earnings
FDA approves Sanofi's Cablivi for rare clotting disease
BioCentury
Wed, 02/6/19 - 03:27 pm
Tags:
Sanofi, Cablivi, aTTP, FDA
CEOs of Pfizer, Merck, Sanofi to testify in Senate drug pricing hearing
Biopharma Dive
Wed, 02/6/19 - 01:27 pm
Tags:
Pfizer, Sanofi, Merck, drug pricing, Senate
Cancer-Vaccine Maker BioNTech Considering an IPO in U.S.
Yahoo/Bloomberg
Wed, 02/6/19 - 09:51 am
Tags:
BioNTech, IPOs, Pfizer, Sanofi, vaccines, cancer vaccines
Powerful Senate committee invites pharma executives to testify
Reuters
Tue, 02/5/19 - 11:31 pm
Tags:
Senate, drug pricing, AbbVie, AstraZeneca, Bristol-Myers Squibb, JNJ, Merck, Pfizer, Sanofi
Sanofi's isatuximab meets survival endpoint for third-line multiple myeloma
BioCentury
Tue, 02/5/19 - 10:09 am
Tags:
Sanofi, FDA, EMA, isatuximab, relapsed or refractory multiple myeloma, Multiple Myeloma
Sanofi Raises Public Health Questions on Use of Nonsense Suffixes With New Vaccines
RAPS.org
Mon, 02/4/19 - 03:15 pm
Tags:
Sanofi, vaccines, drug names, suffixes
On heels of drug pricing hearings, Democratic lawmakers kick off insulin probe
Fierce Pharma
Thu, 01/31/19 - 11:53 pm
Tags:
Sanofi, Novo Nordisk, diabetes, insulin, drug pricing
FDA advisers divided on Sanofi’s oral type 1 diabetes drug
Pharmaforum
Fri, 01/18/19 - 10:26 am
Tags:
Sanofi, Lexicon Pharmaceuticals, type 1 diabetes, Zynquista, FDA, advisory panels, sotagliflozin
Sanofi expands multitargeting toolbox with Biomunex deal
BioCentury
Wed, 01/16/19 - 12:08 am
Tags:
Sanofi, Biomunex Pharmaceuticals, drug development

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.